Prof. Dr. Claus Hellerbrand

Professur für Biochemie und Molekulare Pathobiologie

The delta subunit of rod-specific photoreceptor cgmp phosphodiesterase (Pde6d) contributes to hepatocellular carcinoma progression (2019) Dietrich P, Hellerbrand C, Boßerhoff AK Journal article Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma (2019) Dietrich P, Gaza A, Wormser L, Fritz V, Hellerbrand C, Boßerhoff AK Journal article Pathophysiologie der alkoholischen Fettleber (2019) Hellerbrand C Book chapter / Article in edited volumes BMP6-induced modulation of the tumor micro-milieu (2019) Stieglitz D, Lamm S, Braig S, Feuerer L, Kuphal S, Dietrich P, Arndt S, et al. Journal article Role of melanoma inhibitory activity in melanocyte senescence (2019) Feuerer L, Lamm S, Henz I, Kappelmann-Fenzl M, Haferkamp S, Meierjohann S, Hellerbrand C, et al. Journal article Bone Morphogenetic Protein-6 Inhibits Fibrogenesis in Scleroderma Offering Treatment Options for Fibrotic Skin Disease (2019) Arndt S, Karrer S, Hellerbrand C, Boßerhoff AK Journal article Establishment of a p-nitrophenol oxidation-based assay for the analysis of CYP2E1 activity in intact hepatocytes in vitro (2019) Mahli A, Thasler WE, Hellerbrand C Journal article Hepatic steatosis potentiates irinotecan-induced hepatocellular injury via dysregulation of irinotecan-metabolizing enzymes (2018) Mahli A, Koch A, Thasler W, Hellerbrand C Conference contribution Four-and-a-half LIM-domain protein affects diet induced (hepatic) steatosis and lipid droplet formation (2018) Sommer J, Hellerbrand C Conference contribution Increased expression of pregnancy-associated plasma protein-A in activated hepatic stellate cells is a potential therapeutic target and serum marker of hepatic fibrosis (2018) Kim F, Hellerbrand C Conference contribution